Pitolisant Hcl
Brand name: Wakix
Rank #352 of 500 drugs by total cost
$28.4M
Total Cost
2,361
Total Claims
$28.4M
Total Cost
131
Prescribers
$12K
Cost per Claim
11
Beneficiaries
2,421
30-Day Fills
$217K
Avg Cost/Provider
18
Avg Claims/Provider
About Pitolisant Hcl
Pitolisant Hcl (sold as Wakix) was prescribed 2,361 times by 131 Medicare Part D providers in 2023, costing the program $28.4M. At $12K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 349 | Atenolol (Atenolol) | $28.6M | 2,717,988 |
| 350 | Meloxicam (Meloxicam) | $28.6M | 4,714,084 |
| 351 | Triamcinolone Acetonide (Triamcinolone Acetonide) | $28.5M | 2,307,130 |
| 352 | Pitolisant Hcl (Wakix) | $28.4M | 2,361 |
| 353 | Olanzapine/Samidorphan Malate (Lybalvi) | $28.3M | 18,294 |
| 354 | Interferon Beta-1b (Betaseron) | $28.3M | 2,983 |
| 355 | Iloperidone (Fanapt) | $28.2M | 13,925 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology